PEARLAND, Texas and SEOUL, South Korea, Dec. 28, 2016 /PRNewswire/ — Base Pair Biotechnologies, Inc., The Aptamer Discovery Company, and Nexmos, Inc., the Aptamer Application R&D Company, announce the creation of a new class of DNA-aptamer based oxidation inhibitors.  These molecules stabilize vitamin C, enabling development of new cosmetics, nutraceuticals, beverages and therapeutic agents with longer shelf life and potentially greater efficacy.  Nexmos plans to launch the first product containing these molecules in the second half of 2017, as a component of an antioxidant beverage formulation, in collaboration with a major health beverage company.  Read More